- Home
- MSC vs MSLE Comparison
MSC vs MSLE Comparison
Compare MSC & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSC | MSLE |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | Hong Kong | Canada |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.9M | 144.6M |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | MSC | MSLE |
|---|---|---|
| Price | $0.79 | $6.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $24.17 |
| AVG Volume (30 Days) | ★ 88.4K | 45.1K |
| Earning Date | 11-04-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $5.44 |
| 52 Week High | $4.19 | $13.39 |
Technical Indicators
Market Signals| Indicator | MSC | MSLE |
|---|---|---|
| Relative Strength Index (RSI) | 34.70 | 39.25 |
| Support Level | $0.76 | $5.52 |
| Resistance Level | $1.10 | $10.58 |
| Average True Range (ATR) | 0.07 | 0.53 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 15.18 | 28.57 |
Price Performance
Historical ComparisonAbout MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About MSLE Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.